undamentalytics Newsletter
Sign in

Silicon Laboratories Inc. (SLAB) stock

Add to watchlist

Add holding +

NASDAQ: SLAB Nasdaq Semiconductors Next results ~November 3, 2026

C Fundamentals grade

Silicon Laboratories designs chips and software for wireless connectivity in the Internet of Things. Its products are analogue-intensive, mixed-signal integrated circuits made in standard CMOS, combining functions that would otherwise need several discrete parts onto a single chip or system-on-chip. The range covers wireless microcontrollers and SoCs — including the EFM32, EFM8 and 8051 families — supporting Bluetooth, Wi-Fi, Zigbee, Z-Wave, Thread, Wi-SUN and sub-GHz radio, with the Simplicity Studio toolset.

The company is fabless, outsourcing wafer production to foundries, chiefly TSMC and SMIC, and earns revenue by selling to makers of connected devices. It reaches them through a direct sales force and a network of independent representatives and distributors, on individual purchase orders; two distributors, Arrow Electronics and Edom Technology, account for much of its sales.

Products address two markets, Industrial & Commercial and Home & Life, spanning applications from smart metering to door locks and glucose monitors. With sales offices in Asia, the Americas and Europe, 91% of fiscal 2025 revenue came from outside the United States. It employed 1,930 people in January 2026, 72% in engineering, and in February 2026 agreed to be acquired by Texas Instruments.

Based on Silicon Laboratories Inc.'s 10-K filed February 10, 2026.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$84

Valuation models combined (5)

Base case. Range ~$65–$130. Weighted average of 5 models (forward price-to-earnings vs peers, residual income, justified price-to-book, forward price-to-sales vs peers, revenue-to-maturity model).

Price vs value

No Buy/Hold/Sell rating is issued: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Silicon Laboratories Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders0 buying, 4 selling0 purchases and 5 sales by directors and officers, last 12 monthsInsider trades
  • Funds157 adding, 182 cuttingOf 53 active managers that changed their stake, 28 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Silicon Laboratories files

Where Silicon Laboratories stands after its latest 10-Q

Revenue for the twelve months to July 2026 was $856m, up 21.7% on a year earlier, slower than 25.1% a quarter earlier. Free-cash-flow margin fell to -0.6% from 10.7% a year earlier. Operating margin widened to -5.1% from -16.1%. Against its peers on growth, profitability, cash generation and balance sheet, it grades D. It passes 2 of our 3 financial-health checks. Our revenue-to-maturity cash-flow model value is $65.22 a share, against a share price of $221.

Source: 10-Q filed August 11, 2026 on SEC EDGAR · Financials · Valuation

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~November 3, 2026 (estimated)

Silicon Laboratories Inc.'s trailing-twelve-month revenue grew 21.7% year on year, with a free-cash-flow margin of -0.6%. Where it stands out: days sales outstanding of 34 days ranks 11 of 62 semiconductor companies we cover.

Current signal Net income rising while operating cash flow falls: TTM net income grew 62.6% while operating cash flow fell 65.1% — earnings and cash are telling different stories.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

  • Fast growth. Revenue grew 21.7% over the last 12 months, against a median of 13.7% for semiconductor companies we cover.
  • Margins widening. Operating margin is up 11.0 points on a year ago.
  • Net cash. Cash exceeds long-term debt by $0.4bn.
  • Beating expectations. Earnings per share beat the analysts' consensus estimate in each of the last four quarters.
  • Estimates rising. Analysts' consensus for next year's earnings per share has risen 5.1% over 90 days.

Things to watch

  • Results due soon. Results are expected around 11 November; the share price can move sharply on the day.
  • Loss-making. Operating margin is -5.1%: costs exceed revenue.
  • Burning cash. Free cash flow was -0.6% of revenue over the last 12 months.
  • Volatile shares. Over the past year the shares showed annualised volatility of 53% and a beta of 0.3 against the S&P 500.
  • Growth easing. The growth rate is 3.4 points lower than a quarter earlier.
  • Below peers: change in growth rate. Change in growth rate of -3.4pp ranks 60 of 75 semiconductor companies we cover (median +3.7pp).

Latest results: FY2026 Q2

Filed August 11, 2026
Earnings per share
$0.71 against an average estimate of $0.69: beat by 3.1%
Revenue
$228m, up 18.3% on a year earlier
Share reaction
+0.2% in the first session after the results on August 11, 2026, against -0.1% for the S&P 500
Next report
November 3, 2026; average EPS estimate $0.85

Silicon Laboratories' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day-0.2%
  • 1 week+0.4%
  • 1 month-0.3%
  • This year+69.9%
  • 1 year+69.4%
  • 5 years+11.6%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$856M
Operating margin
-5.1%
Net margin
-4.6%
EPS (TTM, diluted)
$-1.19

Growth

Revenue growth
+21.7%
Change in growth rate
−3.4 pts
Share count change
+1.6%

Cash

Free cash flow (TTM)
-$5.4M
FCF margin
-0.6%
Stock pay % of revenue
10.2%

Earnings

Last results
August 11, 2026
Next results (est.)
November 11, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Product
  2. Announcement
  3. Announcement
  4. Insider trade
  5. Results
  6. Announcement

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Silicon Laboratories Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: valued with our growth model, which doesn't carry a Buy/Hold/Sell rating yet.

Valuation models

We value Silicon Laboratories Inc. as an operating company, with every model that fits that kind of business. Cost of equity 11.7%: the 10-year Treasury yield (4.9%) plus a beta of 1.51 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Growth cash-flow model Revenue for this year and next from analysts' consensus, then growth fading to 2.5%; the operating margin moving to profitable peers'; investment needed per dollar of growth from peers; reduced by a failure probability. For young or fast-growing companies. The starting margin is normalized to between -100% and 60%; net margin is a proxy when operating income is not tagged. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$41 ~$30–$49 Left out: out of range vs price (0.18x)
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$65 ~$62–$110 Included
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$130 ~$93–$180 Included
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$83 ~$74–$93 Included
Forward price-to-sales vs peers Next year's consensus sales per share times peers' typical forward price-to-sales; only when earnings are negative. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$73 ~$70–$200 Included, half weight
Revenue-to-maturity model Revenue grown to maturity with the cash margin moving to the industry's; for companies not yet profitable. ~$67 ~$56–$81 Included
Combined value Weighted average of the models that apply: the primary model (growth cash-flow model) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$84 ~$65–$130 5 models

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Silicon Laboratories Inc. with Semiconductors in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Valuation multiples over time Market data may be delayed

At fiscal year end 20152016201720182019202020212022202320242025Now
Share price$48.54$65.00$88.30$78.50$116.52$127.34$206.42$135.67$132.27$127.78$131.93$222.10
Market value$2.1bn$2.8bn$3.8bn$3.5bn$5.2bn$5.7bn$9.1bn$4.9bn$4.2bn$4.1bn$4.3bn$7.3bn
+ Net debt (− = net cash)−$37m−$69m$73m$158m$141m$361m−$1.1bn$30m−$228m−$282m−$364m−$362m
Enterprise value$2.0bn$2.7bn$3.9bn$3.6bn$5.3bn$6.0bn$8.1bn$4.9bn$4.0bn$3.8bn$4.0bn$7.0bn
Multiples
Price / sales 3.2x3.9x5.0x4.0x10.9x11.1x12.7x4.8x5.4x7.0x5.5x8.6x
Price / earnings 70.5x44.8x81.2x41.4xn/mn/m4.3x53.5x————
Price / free cash flow 22.1x23.3x21.6x23.2x34.1x48.0x146.1x42.6x——65.6x—
EV / EBITDA 45.8x33.8x39.1x35.8x———34.7xn/m———

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

67 /100

Moderate moat

How hard Silicon Laboratories's competitive advantage looks for rivals to wear away, judged from 10 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 20 / 20

    Cash operating profit has been a median 18.0% of total assets over 10 years.

  • Pricing power 19 / 20

    Gross margin has been a median 59.8%, moving by 2.6 percentage points (standard deviation) across 10 years.

  • Durability 0 / 20

    Operating margin has been a median 0.7%; its worst year was -33.3%.

  • Cash conversion 15 / 20

    Free cash flow was positive in 8 of 10 years, at a median 13.1% of revenue.

  • Discipline 13 / 20

    The diluted share count fell 27.1% over five years; stock-based pay has been a median 7.4% of revenue.

AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Next results: November 3, 2026, after the close. Analysts expect revenue of $242m and EPS of $0.85 (range $0.80 to $0.95) for the quarter.

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $2.88 +213% $927m +18%
Next $4.36 +52% $1.1bn +17%

Next year's EPS estimate has moved +5.1% in 90 days, across 7 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +4.2% on 90 days ago. In the last 30 days, 3 analysts raised Silicon Laboratories Inc.'s forecast and 2 cut it.

Consensus EPS forecast Silicon Laboratories Inc., last 90 days
$2.50 $3.00 $3.50 $4.00 $4.50 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $2.76 Current fiscal year, 60 days ago: $2.92 Current fiscal year, 30 days ago: $2.88 Current fiscal year, 7 days ago: $2.88 Current fiscal year, Now: $2.88 $2.88 Next fiscal year, 90 days ago: $4.15 Next fiscal year, 60 days ago: $4.36 Next fiscal year, 30 days ago: $4.36 Next fiscal year, 7 days ago: $4.36 Next fiscal year, Now: $4.36 $4.36

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $2.76$4.15
60 days ago $2.92$4.36
30 days ago $2.88$4.36
7 days ago $2.88$4.36
Now $2.88$4.36

Earnings against estimates

Quarter toEstimateActualSurprise
Jun 2026 $0.69 $0.71 +3.1%
Mar 2026 $0.50 $0.53 +5.2%
Dec 2025 $0.55 $0.56 +2.2%
Sept 2025 $0.31 $0.32 +4.2%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, August 11, 2026

No numeric guidance in Silicon Laboratories Inc.'s latest earnings release (filed August 11, 2026). Some companies give their outlook only on the earnings call.

Analyst recommendations

8 analysts, Nov 2026
Buy00%
Hold8100%
Sell00%

Monthly trend

  1. Nov 202688
  2. Oct 202688
  3. Sep 202688

Counts of recommendations published by analysts covering Silicon Laboratories Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
9.0%
of tradable shares
Days to cover
5.79
at average volume
Short interest, 1 month
−30%
to October 15, 2026
Held by institutions
94%
of shares
Held by insiders
1.6%
of shares
Employees
1,930
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

What moved the share price

Last 12 months +69.4%

$131.08 on October 31, 2025 to $222.10

ThenNowEffect
Revenue (last 12 months) $703m $856m +21.7%
P/S multiple 6.1x 8.6x +41.4%
Share count 32m 33m −1.5%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

Last 3 years +142.6%

$91.54 on November 3, 2023 to $222.10

ThenNowEffect
Revenue (last 12 months) $1.0bn $856m −16.0%
P/S multiple 3.0x 8.6x +182.8%
Share count 34m 33m +2.1%

Biggest factor: p/s multiple. Loss-making at one end, so the split uses price/sales.

The effects multiply back to the price change exactly. Results are the last 12 months as known on each date (filings assumed public 45 days after quarter end).

Return and risk by year

Calendar year 202120222023202420252026 to date
Return
SLAB+62%−34%−3%−6%+5%+70%
Industry peers (median)+35%−39%+16%−15%+19%+13%
S&P 500+29%−18%+26%+25%+18%+11%
Months that ended higher
SLAB58%25%50%50%50%73%
S&P 50075%42%67%75%75%46%
Largest fall from a high during the year
SLAB−25%−45%−55%−38%−46%−11%
S&P 500−5%−25%−10%−8%−19%−9%

Worst fall since October 29, 2015: 59% from November 16, 2021 to April 8, 2025. Getting back needed a 144% gain, reached on April 8, 2026, 365 days after the low.

Price behaviour

52-week range
$116.08 – $222.80
From 52-week high
−0.3%
vs 50-day average
+0.6%
vs 200-day average
+5.1%
Volatility (1 year)
53%
Beta vs S&P 500
0.32

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
7 up, 5 down
typical move ±8.5%
After a week
8 up, 4 down
typical move ±8.1%
After a month
10 up, 2 down
typical move ±10.1%
Results releasedNext dayS&P 500 next day5 days21 days
August 11, 2026 +0.2% −0.1% +0.3% +0.3%
May 5, 2026 −0.2% +2.2% −0.2% +0.9%
February 4, 2026 +50.2% −1.7% +51.6% +48.4%
November 4, 2025 +1.2% −0.8% −0.3% +8.4%
August 5, 2025 −7.3% +0.3% −2.0% +1.0%
May 13, 2025 +5.3% +0.8% +1.7% +11.7%
February 4, 2025 +10.6% +1.1% +9.6% +0.3%
November 4, 2024 −1.7% +1.0% +2.0% +5.0%
July 24, 2024 +0.3% −2.8% +3.3% −2.7%
April 24, 2024 −5.2% −0.4% −5.3% −0.9%
February 7, 2024 +16.0% +0.9% +19.1% +23.7%
November 1, 2023 −4.2% +3.0% +2.3% +18.3%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Silicon Laboratories Inc. in five measures

Fundamentals grade C
Growth Profitability Cash Balance sheet

Growth, profitability, cash generation and balance sheet are percentiles against the companies we cover in the same industry, from SEC filings (100 = best). Value compares the share price with our modelled value range (50 = at our base value; higher = cheaper). A description of reported data and our model — not a quality score or advice.

Fundamentals

Revenue (TTM) Silicon Laboratories Inc.
$400M $600M $800M $1B FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue (TTM), FY23 Q3: $952.7M Revenue (TTM), FY23 Q4: $782.3M Revenue (TTM), FY24 Q1: $641.8M Revenue (TTM), FY24 Q2: $542.3M Revenue (TTM), FY24 Q3: $505M Revenue (TTM), FY24 Q4: $584.4M Revenue (TTM), FY25 Q1: $655.7M Revenue (TTM), FY25 Q2: $703.2M Revenue (TTM), FY25 Q3: $742.8M Revenue (TTM), FY25 Q4: $784.8M Revenue (TTM), FY26 Q1: $820.6M Revenue (TTM), FY26 Q2: $855.9M $855.9M

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue (TTM)
FY23 Q3 $952.7M
FY23 Q4 $782.3M
FY24 Q1 $641.8M
FY24 Q2 $542.3M
FY24 Q3 $505M
FY24 Q4 $584.4M
FY25 Q1 $655.7M
FY25 Q2 $703.2M
FY25 Q3 $742.8M
FY25 Q4 $784.8M
FY26 Q1 $820.6M
FY26 Q2 $855.9M
Revenue growth, TTM YoY Silicon Laboratories Inc.
-50% 0% 50% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Revenue growth, TTM YoY, FY23 Q3: -2.3% Revenue growth, TTM YoY, FY23 Q4: -23.6% Revenue growth, TTM YoY, FY24 Q1: -38.1% Revenue growth, TTM YoY, FY24 Q2: -46.8% Revenue growth, TTM YoY, FY24 Q3: -47.0% Revenue growth, TTM YoY, FY24 Q4: -25.3% Revenue growth, TTM YoY, FY25 Q1: 2.2% Revenue growth, TTM YoY, FY25 Q2: 29.7% Revenue growth, TTM YoY, FY25 Q3: 47.1% Revenue growth, TTM YoY, FY25 Q4: 34.3% Revenue growth, TTM YoY, FY26 Q1: 25.1% Revenue growth, TTM YoY, FY26 Q2: 21.7% 21.7%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q3 -2.3%
FY23 Q4 -23.6%
FY24 Q1 -38.1%
FY24 Q2 -46.8%
FY24 Q3 -47.0%
FY24 Q4 -25.3%
FY25 Q1 2.2%
FY25 Q2 29.7%
FY25 Q3 47.1%
FY25 Q4 34.3%
FY26 Q1 25.1%
FY26 Q2 21.7%
Operating margin (TTM) Silicon Laboratories Inc.
-60% -40% -20% 0% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 Operating margin (TTM), FY23 Q3: 7.7% Operating margin (TTM), FY23 Q4: -3.1% Operating margin (TTM), FY24 Q1: -16.0% Operating margin (TTM), FY24 Q2: -31.0% Operating margin (TTM), FY24 Q3: -41.6% Operating margin (TTM), FY24 Q4: -28.3% Operating margin (TTM), FY25 Q1: -21.1% Operating margin (TTM), FY25 Q2: -16.1% Operating margin (TTM), FY25 Q3: -12.9% Operating margin (TTM), FY25 Q4: -9.0% Operating margin (TTM), FY26 Q1: -6.8% Operating margin (TTM), FY26 Q2: -5.1% -5.1%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q3 7.7%
FY23 Q4 -3.1%
FY24 Q1 -16.0%
FY24 Q2 -31.0%
FY24 Q3 -41.6%
FY24 Q4 -28.3%
FY25 Q1 -21.1%
FY25 Q2 -16.1%
FY25 Q3 -12.9%
FY25 Q4 -9.0%
FY26 Q1 -6.8%
FY26 Q2 -5.1%
FCF margin (TTM) Silicon Laboratories Inc.
-20% -10% 0% 10% 20% FY23 Q3 FY24 Q2 FY25 Q1 FY26 Q2 FCF margin (TTM), FY23 Q3: -6.3% FCF margin (TTM), FY23 Q4: -6.7% FCF margin (TTM), FY24 Q1: -16.4% FCF margin (TTM), FY24 Q2: -15.7% FCF margin (TTM), FY24 Q3: -3.4% FCF margin (TTM), FY24 Q4: -4.4% FCF margin (TTM), FY25 Q1: 13.9% FCF margin (TTM), FY25 Q2: 10.7% FCF margin (TTM), FY25 Q3: 9.9% FCF margin (TTM), FY25 Q4: 8.4% FCF margin (TTM), FY26 Q1: 2.1% FCF margin (TTM), FY26 Q2: -0.6% -0.6%

Source: SEC EDGAR filings. Retrieved October 20, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q3 -6.3%
FY23 Q4 -6.7%
FY24 Q1 -16.4%
FY24 Q2 -15.7%
FY24 Q3 -3.4%
FY24 Q4 -4.4%
FY25 Q1 13.9%
FY25 Q2 10.7%
FY25 Q3 9.9%
FY25 Q4 8.4%
FY26 Q1 2.1%
FY26 Q2 -0.6%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2009 Jan 2010 2010 Jan 2011 2011 Dec 2011 2012 Dec 2012 2013 Dec 2013 2014 Jan 2015 2015 Jan 2016 2016 Dec 2016 2017 Dec 2017 2018 Dec 2018 2019 Dec 2019 2020 Jan 2021 2021 Jan 2022 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Jan 2026 LTM Jul 2026
Income
Revenue 441 493 492 563 580 621 645 698 769 868 474 511 721 1,024 782 584 785 856
Gross profit 280 324 298 338 353 379 381 422 454 521 280 295 425 643 461 312 457 519
EBITDA 78 98 64 99 78 64 45 79 100 101 −73 −91 −15 142 2 −140 −46 −19
Operating income 67 87 50 86 64 51 32 66 85 85 −89 −107 −33 119 −24 −165 −71 −43
Net income 73 73 35 64 50 38 30 61 47 84 19 13 2,117 91 −35 −191 −65 −39
Diluted EPS $1.57 $1.57 $0.79 $1.47 $1.14 $0.87 $0.69 $1.45 $1.09 $1.90 $0.43 $0.28 $47.78 $2.54 −$1.09 −$5.93 −$1.98 −$1.19
Growth (year on year)
Revenue +6.1% +11.9% −0.3% +14.6% +3.0% +7.0% +3.9% +8.2% +10.2% +12.9% −45.4% +7.8% +41.1% +42.1% −23.6% −25.3% +34.3% +21.7%
EBITDA +44.1% +25.6% −35.4% +56.0% −21.6% −17.8% −30.1% +77.6% +25.5% +1.4% −172.6% — — — −98.9% — — —
Operating income +52.4% +30.3% −42.2% +71.1% −24.9% −20.0% −37.3% +105.6% +28.2% +0.3% −204.0% — — — −120.3% — — —
Net income +121.9% +0.2% −51.6% +79.1% −21.6% −23.7% −22.2% +107.8% −23.4% +77.5% −77.0% −35.0% +>999% −95.7% −137.8% — — —
Diluted EPS +134.3% 0.0% −49.7% +86.1% −22.4% −23.7% −20.7% +110.1% −24.8% +74.3% −77.4% −34.9% +>999% −94.7% −142.9% — — —
Margins
Gross margin 63.4% 65.7% 60.7% 60.0% 60.8% 61.0% 59.0% 60.4% 59.1% 60.1% 59.1% 57.7% 59.0% 62.7% 58.9% 53.4% 58.2% 60.6%
EBITDA margin 17.8% 20.0% 12.9% 17.6% 13.4% 10.3% 6.9% 11.4% 13.0% 11.6% −15.5% −17.8% −2.1% 13.8% 0.2% −23.9% −5.8% −2.2%
Operating margin 15.1% 17.6% 10.2% 15.2% 11.1% 8.3% 5.0% 9.5% 11.1% 9.8% −18.7% −21.0% −4.6% 11.6% −3.1% −28.3% −9.0% −5.1%
Net margin 16.6% 14.8% 7.2% 11.3% 8.6% 6.1% 4.6% 8.8% 6.1% 9.6% 4.1% 2.5% 293.7% 8.9% −4.4% −32.7% −8.3% −4.6%
Free-cash-flow margin 25.4% 21.1% 16.3% −0.9% 18.9% 20.3% 14.6% 16.9% 23.1% 17.2% 31.9% 23.0% 8.7% 11.2% −6.7% −4.4% 8.4% −0.6%
Cash flow
Cash from operations 121 118 89 97 120 137 105 129 190 174 167 136 91 141 −30 −14 96 33
Capital spending 9 14 9 102 10 11 11 11 12 24 15 18 29 27 22 12 30 39
Free cash flow 112 104 80 −5 110 126 94 118 177 149 151 118 63 115 −53 −26 66 −5
Stock-based pay 44 40 36 31 31 39 43 40 45 50 44 49 57 61 48 62 80 87
Free cash flow after stock pay 68 64 44 −36 79 87 51 78 133 99 107 68 6 54 −101 −87 −15 −93
Balance sheet
Cash 196 139 95 105 96 142 114 141 269 197 227 203 1,075 500 228 282 364 362
Total debt 0 0 0 100 95 88 78 73 342 355 368 563 — 530 — 0 0 0
Net debt (negative = net cash) −196 −139 −95 −5 −1 −54 −37 −69 73 158 141 361 −1,075 30 −228 −282 −364 −362
Diluted shares 47m 47m 45m 43m 44m 44m 43m 42m 43m 44m 44m 44m 44m 36m 32m 32m 33m 33m
Returned to shareholders
Buybacks 20 140 110 62 26 72 71 41 — 39 27 16 1,150 883 217 0 0 —
Total returned 20 140 110 62 26 72 71 41 — 39 27 16 1,150 883 217 0 0 —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

2 of 3 checks passed · July 4, 2026
What it owns · $1.3bn
Short-term assets $671mLonger-term assets $582m
What it owes, and who funded it · $1.3bn
Short-term liabilities $124mLonger-term liabilities $34mShareholders' equity $1.1bn
  • Short-term assets cover short-term liabilities $671m of assets due within a year against $124m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $671m short-term assets against $34m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Operating income of −$43m against $923,000 of interest.

From Silicon Laboratories Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Dividends, buybacks and capital spending

Buybacks, last 3 fiscal years
$217M
Diluted share count
+1.6%
year over year
R&D spending
42.2%
of revenue
Sales & admin spending
23.5%
of revenue
Days sales outstanding
34 days
receivables vs revenue

Competitors: side by side with peers

Closest by revenue in semiconductors
Last 12 months unless stated SLAB PLAB HIMX SIMO FORM RMBS Median
Revenue, last 12 months $856m $867m $832m $886m $902m $796m $1.1bn
Revenue growth, last 12 months 21.7% 1.2% −8.2% 10.2% 18.0% 17.3% 13.7%
Revenue growth, 3-year average −5.6% −0.3% — 57.8% 10.4% 20.0% 3.9%
Revenue growth, latest quarter 18.3% 2.7% — — 31.9% 22.3% 20.1%
Gross margin 60.6% 33.7% 30.6% 48.3% 43.1% 79.1% 48.3%
Operating margin −5.1% 22.5% 5.3% 10.5% 12.9% 36.3% 4.8%
Operating margin, 3-year average −17.4% 24.5% 13.9% 18.5% 11.9% 34.6% 4.8%
Net margin −4.6% 19.0% 5.3% 13.8% 12.8% 33.4% 5.3%
Cash from operations / revenue 3.9% 35.6% 16.8% 6.9% 19.9% 43.6% 17.4%
Free-cash-flow margin −0.6% 12.7% 14.4% 0.7% 15.1% 39.3% 9.6%
Free-cash-flow margin, 3-year average −1.9% 12.9% 12.5% 11.5% 7.4% 40.4% 8.5%
Stock pay / revenue 10.2% 1.6% 0.1% 3.0% 4.0% 7.4% 5.8%
Change in share count 1.6% −4.2% −0.2% −0.1% 1.6% 0.9% 0.9%

Median of all 75 companies we cover in semiconductors. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

75 semiconductor companies
Measure Company Peer median Rank
Revenue growth Growth 21.7% 13.7% 27 of 75
Change in growth rate Growth -3.4pp +3.7pp 60 of 75
Gross margin Profitability 60.6% 48.3% 15 of 73
Operating margin Profitability -5.1% 4.8% 52 of 75
Net margin Profitability -4.6% 5.3% 50 of 75
Free-cash-flow margin Cash generation -0.6% 9.6% 51 of 75
Stock pay as % of revenue Cash generation 10.2% 6.4% 50 of 74
Change in share count Balance sheet 1.6% 0.9% 41 of 72
Days sales outstanding Balance sheet 34 days 58 days 11 of 62

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to January 3, 2026
Products and services
Line of business Revenue Share YoY
Industrial Commercial $445M 56.7% ▲ 31.4%
Home Life $340M 43.3% ▲ 38.2%
Geography
Region Revenue Share YoY
Rest of World $329M 41.9% ▲ 25.3%
China $257M 32.8% ▲ 36.6%
Taiwan $131M 16.6% ▲ 68.6%
United States $68.5M 8.7% ▲ 21.3%

From Silicon Laboratories Inc.'s 10-K filed February 10, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$6.8B
Institutions reporting
352
Shares held vs prior quarter
▲ 3.6%
Positions opened / closed
29 / 55

Top buyers and sellers, Q2 2026: 157 institutions bought and 182 sold ; the biggest buyer was HBK Investments L P (+1.0M shares) and the biggest seller Nomura Asset Management International Inc (−645K). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $1.1B 5.2M 16.7% ▲ 4.0%
Vanguard Portfolio Management LLC $456M 2.1M 6.7% ▼ 2.4%
State Street Corp $355M 1.6M 5.2% ▲ 10.7%
Balyasny Asset Management L.P. $341M 1.6M 5.0% ▲ 26.4%
Vanguard Capital Management LLC $325M 1.5M 4.8% ▲ 0.8%
Millennium Management LLC $219M 1.0M 3.2% ▲ 119.5%
HBK Investments L P $219M 1.0M 3.2% New
Geode Capital Management, LLC $198M 905K 2.9% ▲ 6.3%
UBS Group AG $168M 770K 2.5% ▲ 102.0%
Goldman Sachs Group Inc $163M 747K 2.4% ▲ 43.6%
Pentwater Capital Management LP $162M 742K 2.4% ▲ 48.3%
AQR Arbitrage LLC $141M 643K 2.1% ▲ 108.2%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Silicon Laboratories Inc.'s complete shareholder register. Values are as reported by the filers .

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $4.2M 5 trades by 4 insiders · 59% under pre-set plans
Net ▼ $4.2M net selling
Insider Date Trade Shares Price Value
Conrad Robert J Sr VP and General Manager August 14, 2026 Sell pre-set plan 6,581 $218.21 $1.4M
Johnson Robert Matthew President & CEO May 18, 2026 Sell 8,024 $216.83 $1.7M
Richardson Nina Director January 13, 2026 Sell pre-set plan 1,355 $149.00 $201,895
Tolany Brandon Sr VP WW Sales & Marketing December 5, 2025 Sell pre-set plan 1,954 $141.49 $276,471
Tolany Brandon Sr VP WW Sales & Marketing December 4, 2025 Sell pre-set plan 4,246 $140.17 $595,162

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Trades by members of Congress

All 6 trades and filings

No trades in Silicon Laboratories Inc. disclosed in the last 12 months; 6 earlier trades on record.

  • Gilbert Ray Cisneros, Jr.(D-CA 31):Sale (full), $1,001 - $15,000, traded May 6, 2025, filed June 6, 2025
  • Gilbert Ray Cisneros, Jr.(D-CA 31):Sale (partial), $1,001 - $15,000, traded April 14, 2025, filed May 6, 2025
  • Josh Gottheimer(D-NJ 5):Sale (partial), $1,001 - $15,000, traded February 26, 2021, filed March 10, 2021

Value ranges as filed; reports can arrive up to 45 days after a trade.

Earnings dates and SEC filings

Results announcements

Next expected around November 11, 2026 estimated from the company's past filing pattern, not announced

  • August 11, 2026
  • May 5, 2026
  • February 4, 2026
  • November 4, 2025
  • August 5, 2025
  • May 13, 2025

Recent SEC filings

Data status

When each part of this page on Silicon Laboratories Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Silicon Laboratories Inc. in brief

What does Silicon Laboratories Inc. do?
Silicon Laboratories Inc. is a US-listed company in the semiconductors industry. Its financial year ends in December.
What is Silicon Laboratories Inc.'s stock ticker?
Silicon Laboratories Inc. trades under the ticker SLAB on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Silicon Laboratories Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Silicon Laboratories Inc. reported revenue of $856M, 21.7% higher than a year earlier, according to its SEC filings.
What is Silicon Laboratories Inc.'s free cash flow?
Silicon Laboratories Inc.'s free-cash-flow margin is -0.6% of revenue over the trailing twelve months, ranking 51 of the 75 semiconductor companies we cover.
Who are Silicon Laboratories Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vanguard Portfolio Management LLC and State Street Corp. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
What is Silicon Laboratories Inc.'s market cap?
On November 2, 2026, Silicon Laboratories Inc.'s market capitalisation was about $7.3B and net debt of -$362M. Market figures come from third-party market data and may be delayed.
Who are Silicon Laboratories Inc.'s competitors?
In our Semiconductors peer group, the companies closest to Silicon Laboratories Inc. are Photronics Inc, Himax Technologies, Inc., Silicon Motion Technology Corp, Formfactor Inc and Rambus Inc. The side-by-side comparison below sets their revenue, margins and growth against Silicon Laboratories Inc.'s.
Are insiders buying or selling Silicon Laboratories Inc. stock?
Over the last 12 months, Silicon Laboratories Inc.'s directors and officers reported 0 open-market purchases and 5 sales on Form 4. The insider trading page charts every trade.
When is Silicon Laboratories Inc.'s next earnings date?
Around November 3, 2026, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Silicon Laboratories Inc. announces its own schedule.